Johnson & Johnson's Synthes Acquisition Adds 5.6% 4Q Sales Growth Featured

Written by  Laura Dyrda | Friday, 25 January 2013 15:22
Social sharing
Johnson & Johnson's acquisition of Sythnes contributed to 5.6 percent to worldwide operational sales growth, net of the divestiture of the DePuy trauma business necessary for the acquisition.
The acquisition contributed to 3.1 percent worldwide operational sales growth on the full year. Johnson & Johnson's orthopedics business experienced 60.8 percent sales growth during the fourth quarter and 34 percent sales growth over the entire year in the United States. Worldwide, the company's orthopedics business saw a 64.3 percent sales growth to $2.3 billion in the fourth quarter and 34.3 percent sales growth over the full year to $7.7 billion.

More Articles on Orthopedic Device:

Implant Device Market to Reach $73.9B Value in 2018

6 Potential Effects of the Medical Device Tax on Orthopedics Companies

Zimmer Introduces Its 1st Lateral Plate System for Spinal Trauma

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months